Advanced search
Publication Cover
Acta Cardiologica Volume 72, 2017 - Issue 4
Submit an article Journal homepage
98
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Serum allantoin and aminothiols as biomarkers of chronic heart failure

Elizabeth CausséBiochemistry Laboratory, Rangueil University Hospital, Toulouse, France; Correspondence[email protected]
, MD,
Pauline FournierDepartment of Cardiology, Rangueil University Hospital, Toulouse, France;
, MD,
Jérome RoncalliDepartment of Cardiology, Rangueil University Hospital, Toulouse, France; ;INSERM UMR 1048, Toulouse, France
, MD, PhD,
Robert SalvayreBiochemistry Laboratory, Rangueil University Hospital, Toulouse, France; ;INSERM UMR 1048, Toulouse, France
, MD, PhD &
Michel GalinierDepartment of Cardiology, Rangueil University Hospital, Toulouse, France; ;INSERM UMR 1048, Toulouse, France
, MD, PhD
Pages 397-403 | Received 17 Jun 2016, Accepted 31 Aug 2016, Published online: 14 Jul 2017

REFERENCES

  • Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011; 301: H2181–90.
  • Hafstad AD, Nabeebaccus AA, Shah AM. Novel aspects of ROS signalling in heart failure. Basic Res Cardiol 2013; 108: 359.
  • Bhimaraj A, Tang WH. Role of oxidative stress in disease progression in stage B heart failure. Heart Fail Clin 2012; 8: 101–11.
  • van Kimmenade RR, Januzzi JL. Emerging biomarkers in heart failure. Clin Chem 2012; 58: 127–38.
  • Campolo J, Caruso R, De Maria R, Parolini M, Oliva F, Roubina E, Cighetti G, Frigerio M, Vitali E, Parodi O. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin. J Cardiovasc Med (Hagerstown) 2007; 8: 1024–8.
  • Joseph J, Loscalzo J. Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology. Nutrients 2013; 5: 3235–56.
  • Hoffman M. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress. Med Hypotheses 2011; 77: 1088–93.
  • Schalinske KL, Smazal AL. Homocysteine imbalance: a pathological metabolic marker. Adv Nutr 2012; 3: 755–62.
  • Campolo J, De Maria R, Caruso R, Accinni R, Turazza F, Parolini M, Roubina E, De Chiara B, Cighetti G, Frigerio M, Vitali E, Parodi O. Blood glutathione as independent marker of lipid peroxidation in heart failure. Int J Cardiol 2007; 117: 45–50.
  • Focks JJ, van Schaik A, Clappers N, van Dijk EG, van Oijen MG, Verheugt FW, Peters WH. Assessment of plasma aminothiol levels and the association with recurrent atherothrombotic events in patients hospitalized for an acute coronary syndrome: a prospective study. Clin Chem Lab Med 2013; 51: 2187–93.
  • Franceschi F, Deharo JC, Giorgi R, By Y, Monserrat C, Condo J, Ibrahim Z, Saadjian A, Guieu R. Peripheral plasma adenosine release in patients with chronic heart failure. Heart 2009; 95: 651–5.
  • Bauer JA, Moffatt-Bruce SD, Elton TS, Feldman D. Purine metabolism in heart failure: oxidant biology and therapeutic indications. Congest Heart Fail 2008; 14: 283–4.
  • Caussé E, Ribes D, Longlune N, Kamar N, Durand D, Salvayre R, Rostaing L. Aminothiols and allantoin in chronic dialysis patients: effects of hemodialysis sessions. Clin Nephrol 2010; 73: 51–7.
  • Harzand A, Tamariz L, Hare JM. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition. Congest Heart Fail 2012; 18: 179–82.
  • Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol 2013; 14: 164–72.
  • Caussé E, Pradelles A, Dirat B, Salvayre R, Couderc F. Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE. Electrophoresis 2007; 28: 381–7.
  • Gibelin P, Serre S, Candito M, Houcher B, berthier F, Baudouy M. Prognostic value of homocysteinemia in patients with congestive heart failure. Clin Chem Lab Med 2006; 44: 813–6.
  • Fournier P, Fourcade J, Roncalli J, Salvayre R, Galinier M, Caussé E. Homocysteine in chronic heart failure. Clin Lab 2015; 61: 1137–45.
  • Mangoni AA, Zinellu A, Carru C, Attia JR, McEvoy M. Serum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate/product ratios. J Transl Med 2013; 11: 99–108.
  • Bearden SE, Beard RS, Pfau JC. Extracellular transsulfuration generates hydrogen sulfite from homocysteine and protects endothelium from redox stress. Am J Physiol Heart Circ Physiol 2010; 299: H1568–76.
  • Kinugawa T, Fujita M, Ogino K, Kato M, Osaki S, Igawa O, Shigemasa C, Hisatome I, Kitakaze M. Catabolism of adenine nucleotides favors adenosine production following exercise in patients with chronic heart failure. J Card Fail 2006; 12: 720–5.
  • Niebauer J, Clark AL, Webb-Peploe KM, Boger R, Coats AJ. Home-based exercise training modulates pro-oxidant subtrates in patients with chronic heart failure. Eur J Heart Fail 2005; 7: 183–8.
  • Vaduganathan M,Greene SJ, Ambrosy AP, Mentz RJ, Subacius HP, Chioncel O, Maggioni AP, Swedberg K, Zannad F, Konstam MA, Senni M, Givertz MM, Butler J, Gheorghiade M; EVEREST trial investigators. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonismin heart failure outcome study with tolvaptan trial). Am J Cardiol 2014; 114: 1713–21.
  • Duan Xu, Ling F. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 2008; 70: 578–81.
  • Reyes AJ. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 2005; 7: 461–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.